Pinnacle Wealth Planning Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Pinnacle Wealth Planning Services, Inc.

$838 Million
Q3 2025

A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 461 shares of REGN stock, worth $319,703. This represents 0.03% of its overall portfolio holdings.

Number of Shares

461

Previous 475 2.95%

Holding current value

$319,703

Previous $249,000 4.02%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$534.91 - $598.71 $7,488 - $8,381	-14 Reduced 2.95%	461 $259,000
Q2 2025 Aug 11, 2025	SELL	$483.07 - $625.6 $6,762 - $8,758	-14 Reduced 2.86%	475 $249,000
Q1 2025 May 15, 2025	BUY	$634.14 - $744.83 $8,877 - $10,427	14 Added 2.95%	489 $310,000
Q4 2024 Feb 06, 2025	SELL	$701.85 - $1046.91 $96,153 - $143,426	-137 Reduced 22.39%	475 $338,000
Q2 2024 Aug 09, 2024	BUY	$883.2 - $1071.19 $883 - $1,071	1 Added 0.16%	612 $643,000

Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $1,550 - $1,763	-2 Reduced 0.33%	611 $536,000
Q3 2023 Nov 07, 2023	SELL	$692.45 - $844.37 $2,077 - $2,533	-3 Reduced 0.49%	613 $504,000
Q2 2023 Aug 07, 2023	SELL	$700.03 - $830.35 $6,300 - $7,473	-9 Reduced 1.44%	616 $442,000
Q1 2023 May 03, 2023	BUY	$680.49 - $826.97 $1,360 - $1,653	2 Added 0.32%	625 $513,000
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $8,470 - $9,196	12 Added 1.96%	623 $449,000
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $17,219 - $21,729	30 Added 5.16%	611 $421,000
Q2 2022 Aug 03, 2022	SELL	$548.35 - $738.84 $7,128 - $9,604	-13 Reduced 2.19%	581 $343,000
Q1 2022 Apr 20, 2022	BUY	$595.12 - $698.43 $98,194 - $115,240	165 Added 38.46%	594 $415,000
Q4 2021 Jan 21, 2022	BUY	$543.48 - $670.97 $9,239 - $11,406	17 Added 4.13%	429 $271,000
Q3 2021 Oct 29, 2021	BUY	$574.03 - $680.96 $9,184 - $10,895	16 Added 4.04%	412 $249,000
Q2 2021 Aug 02, 2021	BUY	$472.8 - $558.54 $187,228 - $221,181	396 New	396 $221,000
Q1 2021 Apr 29, 2021	SELL	$446.73 - $548.2 $120,617 - $148,014	-270 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $129,141 - $164,154	270 New	270 $130,000

Others Institutions Holding REGN

# of Institutions

1,466

Shares Held

86.4M

Call Options Held

2.42M

Put Options Held

1.64M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.

Account

Pinnacle Wealth Planning Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History